FTRE
Fortrea Holdings Inc.$10.65+0.05 (+0.47%)Prev Close$10.60·MCap$916.3M·P/E—·Vol1.09M·Yield—
▲
Buys (12M)
2
$507.2K
▼
Sells (12M)
16
$399.5K
◆
Net Activity
Net Buyer
$107.7K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Fortrea Holdings Inc. (FTRE) has been mixed between buying and selling, with 2 insider purchases totaling $507.2K and 16 insider sales totaling $399.5K. The most recent insider transaction was by Mcconnell Jill G. (officer: Chief Financial Officer), who sold $16.6K worth of shares on Mar 17, 2026. Fortrea Holdings Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $916.3M.
FTRE Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Mcconnell Jill G. | officer: Chief Financial Officer | Sell | 1,804 | $9.22 | $16.6K | 72,276 |
| Mar 17, 2026 | Morais Mark A. | officer: Chief Operating Officer | Sell | 1,804 | $9.22 | $16.6K | 69,899 |
| Mar 11, 2026 | Mcconnell Jill G. | officer: Chief Financial Officer | Sell | 5,061 | $9.07 | $45.9K | 72,327 |
| Mar 11, 2026 | Morais Mark A. | officer: Chief Operating Officer | Sell | 4,599 | $9.07 | $41.7K | 69,719 |
| Mar 11, 2026 | Parks Robert | officer: Chief Accounting Officer | Sell | 1,927 | $9.07 | $17.5K | 23,353 |
| Feb 9, 2026 | Mcconnell Jill G. | Chief Financial Officer | Sell | 881 | $13.88 | $12.2K | 0 |
| Feb 9, 2026 | Morais Mark A. | Chief Operating Officer | Sell | 1,179 | $13.88 | $16.4K | 0 |
| Sep 15, 2025 | Parks Robert | Chief Accounting Officer | Sell | 7,338 | $9.95 | $73.0K | 0 |
| Sep 8, 2025 | Hanson James S. | General Counsel | Sell | 1,677 | $10.23 | $17.2K | 0 |
| Sep 8, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 3,156 | $10.23 | $32.3K | 0 |
| Sep 8, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 3,155 | $10.23 | $32.3K | 0 |
| Sep 8, 2025 | Parks Robert | Chief Accounting Officer | Sell | 592 | $10.23 | $6.1K | 0 |
| Sep 2, 2025 | Russell Erin L | Director | Buy | 9,854 | $10.15 | $100.0K | 0 |
| Aug 18, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 4,886 | $8.01 | $39.1K | 0 |
| Aug 8, 2025 | NEUPERT PETER M | Director | Buy | 62,500 | $6.51 | $407.1K | 0 |
| Jun 2, 2025 | Hanson James S. | General Counsel | Sell | 2,191 | $4.17 | $9.1K | 0 |
| Jun 2, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 3,130 | $4.17 | $13.1K | 0 |
| May 14, 2025 | Smith David Ross | Director | Sell | 2,185 | $4.78 | $10.4K | 0 |
| Mar 13, 2025 | Hanson James S. | General Counsel | Sell | 1,007 | $9.70 | $9.8K | 0 |
| Mar 13, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 1,210 | $9.70 | $11.7K | 0 |
| Mar 13, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 1,207 | $9.70 | $11.7K | 0 |
| Mar 12, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 261 | $9.93 | $2.6K | 0 |
| Mar 12, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 203 | $9.93 | $2.0K | 0 |
| Mar 11, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 643 | $9.98 | $6.4K | 0 |
| Mar 11, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 499 | $9.98 | $5.0K | 0 |
| Feb 13, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 540 | $14.67 | $7.9K | 35,335 |
| Feb 13, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 424 | $14.67 | $6.2K | 34,000 |
| Feb 11, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 578 | $14.80 | $8.6K | 34,331 |
| Feb 11, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 773 | $14.80 | $11.4K | 33,214 |
| Jan 14, 2025 | Pike Thomas | Chief Executive Officer | Sell | 11,268 | $18.04 | $203.3K | 159,868 |
| Jun 12, 2024 | Hanson James S. | General Counsel | Buy | 2,000 | $25.30 | $50.6K | 7,475+37% |
| May 30, 2024 | Pike Thomas | Chief Executive Officer | Buy | 10,000 | $24.81 | $248.1K | 57,827 |
| Aug 23, 2023 | NEUPERT PETER M | Director | Buy | 11,000 | $25.30 | $278.3K | 21,996+100% |
| Aug 23, 2023 | Pike Thomas | Chief Executive Officer | Buy | 20,000 | $25.23 | $504.6K | 20,000 |
FTRE Insider Buying Activity
The following table shows recent insider purchases of Fortrea Holdings Inc. (FTRE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Russell Erin L | Director | Buy | 9,854 | $10.15 | $100.0K | 0 |
| Aug 8, 2025 | NEUPERT PETER M | Director | Buy | 62,500 | $6.51 | $407.1K | 0 |
| Jun 12, 2024 | Hanson James S. | General Counsel | Buy | 2,000 | $25.30 | $50.6K | 7,475+37% |
| May 30, 2024 | Pike Thomas | Chief Executive Officer | Buy | 10,000 | $24.81 | $248.1K | 57,827 |
| Aug 23, 2023 | NEUPERT PETER M | Director | Buy | 11,000 | $25.30 | $278.3K | 21,996+100% |
| Aug 23, 2023 | Pike Thomas | Chief Executive Officer | Buy | 20,000 | $25.23 | $504.6K | 20,000 |
FTRE Insider Selling Activity
The following table shows recent insider sales of Fortrea Holdings Inc. (FTRE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Mcconnell Jill G. | officer: Chief Financial Officer | Sell | 1,804 | $9.22 | $16.6K | 72,276 |
| Mar 17, 2026 | Morais Mark A. | officer: Chief Operating Officer | Sell | 1,804 | $9.22 | $16.6K | 69,899 |
| Mar 11, 2026 | Mcconnell Jill G. | officer: Chief Financial Officer | Sell | 5,061 | $9.07 | $45.9K | 72,327 |
| Mar 11, 2026 | Morais Mark A. | officer: Chief Operating Officer | Sell | 4,599 | $9.07 | $41.7K | 69,719 |
| Mar 11, 2026 | Parks Robert | officer: Chief Accounting Officer | Sell | 1,927 | $9.07 | $17.5K | 23,353 |
| Feb 9, 2026 | Mcconnell Jill G. | Chief Financial Officer | Sell | 881 | $13.88 | $12.2K | 0 |
| Feb 9, 2026 | Morais Mark A. | Chief Operating Officer | Sell | 1,179 | $13.88 | $16.4K | 0 |
| Sep 15, 2025 | Parks Robert | Chief Accounting Officer | Sell | 7,338 | $9.95 | $73.0K | 0 |
| Sep 8, 2025 | Hanson James S. | General Counsel | Sell | 1,677 | $10.23 | $17.2K | 0 |
| Sep 8, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 3,156 | $10.23 | $32.3K | 0 |
| Sep 8, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 3,155 | $10.23 | $32.3K | 0 |
| Sep 8, 2025 | Parks Robert | Chief Accounting Officer | Sell | 592 | $10.23 | $6.1K | 0 |
| Aug 18, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 4,886 | $8.01 | $39.1K | 0 |
| Jun 2, 2025 | Hanson James S. | General Counsel | Sell | 2,191 | $4.17 | $9.1K | 0 |
| Jun 2, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 3,130 | $4.17 | $13.1K | 0 |
| May 14, 2025 | Smith David Ross | Director | Sell | 2,185 | $4.78 | $10.4K | 0 |
| Mar 13, 2025 | Hanson James S. | General Counsel | Sell | 1,007 | $9.70 | $9.8K | 0 |
| Mar 13, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 1,210 | $9.70 | $11.7K | 0 |
| Mar 13, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 1,207 | $9.70 | $11.7K | 0 |
| Mar 12, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 261 | $9.93 | $2.6K | 0 |
| Mar 12, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 203 | $9.93 | $2.0K | 0 |
| Mar 11, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 643 | $9.98 | $6.4K | 0 |
| Mar 11, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 499 | $9.98 | $5.0K | 0 |
| Feb 13, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 540 | $14.67 | $7.9K | 35,335 |
| Feb 13, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 424 | $14.67 | $6.2K | 34,000 |
| Feb 11, 2025 | Mcconnell Jill G. | Chief Financial Officer | Sell | 578 | $14.80 | $8.6K | 34,331 |
| Feb 11, 2025 | Morais Mark A. | Chief Operating Officer | Sell | 773 | $14.80 | $11.4K | 33,214 |
| Jan 14, 2025 | Pike Thomas | Chief Executive Officer | Sell | 11,268 | $18.04 | $203.3K | 159,868 |
FTRE Insiders
Similar Stocks to FTRE
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B